Medical Articles

Elinzanetant

Dual neurokinin 1,3 (NK1/NK3) receptor antagonist

Description

First-in-class dual NK1/NK3 receptor antagonist approved for treatment of moderate-to-severe vasomotor symptoms (hot flashes) associated with menopause.

Mechanism of action

Selective antagonist of neurokinin 1 and 3 receptors in hypothalamus; blocks KNDy (kisspeptin/neurokinin B/dynorphin) neuron signaling that regulates core body temperature and thermoregulatory set point.

This page is restricted. Please Login / Register to view this page.

Mechanism of action

Selective antagonist of neurokinin 1 and 3 receptors in hypothalamus; blocks KNDy (kisspeptin/neurokinin B/dynorphin) neuron signaling that regulates core body temperature and thermoregulatory set point.

This page is restricted. Please Login / Register to view this page.